BioCorRx (BICX) Liabilities and Shareholders Equity (2010 - 2026)
BioCorRx (BICX) posted Liabilities and Shareholders Equity of $2.3 million for Q1 2026, up 8.27% sequentially from $2.1 million in Q4 2025, and down 65.82% YoY from $6.8 million in Q1 2025.
BioCorRx (BICX) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
BioCorRx has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 65.82% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (up 124.47% YoY) and the FY2025 annual result came in at $2.1 million, up 456.36% from the prior year.
- Liabilities and Shareholders Equity climbed to $2.3 million in Q1 2026 per BICX's latest filing, from $2.1 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $7.5 million in Q3 2025 and troughed at $317444.0 in Q1 2024.
- A 5-year average of $2.0 million and a median of $766594.0 in 2022 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity jumped 2042.45% in 2025, then tumbled 65.82% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $766594.0 in 2022, then sank by 49.27% to $388887.0 in 2023, then decreased by 0.76% to $385941.0 in 2024, then soared by 456.36% to $2.1 million in 2025, then rose by 8.27% to $2.3 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.3 million, $2.1 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 63.25 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 30.68 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 7.46 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 17.71 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 5.75 Bn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 15.94 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 5.66 Bn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 1.58 Bn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 3.01 Bn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.32 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 6.68 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 385,941.00 |
| Sep 30, 2024 | 643,570.00 |
| Jun 30, 2024 | 478,535.00 |
| Mar 31, 2024 | 317,444.00 |
| Dec 31, 2023 | 388,887.00 |
| Sep 30, 2023 | 534,446.00 |
| Jun 30, 2023 | 756,759.00 |
| Mar 31, 2023 | 709,161.00 |
| Dec 31, 2022 | 766,594.00 |
| Sep 30, 2022 | 819,249.00 |
| Jun 30, 2022 | 890,055.00 |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 819,975.00 |
| Sep 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.59 Mn |